# Establishment of age-stratified serum vitamin B6 pyridoxal and pyridoxic acid reference intervals among children aged 1–16 years in Henan, china

**Authors:** Yusheng Luan, Nan Chen, Xucheng Wang, Xiaojuan Li, Junmei Yang, Tiewei Li

PMC · DOI: 10.3389/fnut.2025.1592045 · 2025-07-30

## TL;DR

This study establishes age-specific reference ranges for vitamin B6 metabolites in children in Henan, China, to improve diagnostic accuracy.

## Contribution

The study provides the first age-stratified reference intervals for B6-PL and B6-PA in Chinese children aged 1–16 years.

## Key findings

- Serum B6-PL and B6-PA levels vary significantly with age but not with gender in children.
- Reference intervals for B6-PL and B6-PA were established for three age groups (1–5, 6–11, and 12–16 years).

## Abstract

The development of population-specific reference intervals (RIs) for serum vitamin B6 (B6) in Chinese pediatric populations has not been established. Current clinical practice relies on international thresholds, but diagnostic sensitivity with domestic biochemical profiles remains suboptimal. This study aims to establish age-stratified reference intervals for serum vitamin B6 pyridoxal (B6-PL) and pyridoxic acid (B6-PA) in Henan children aged 1–16 years.

This retrospective study analyzed 1,458 healthy children undergoing routine physical examinations at Henan Children’s Hospital from December 2021 to June 2024. Serum B6-PL and B6-PA were quantified using the Xevo TQ-S Micro liquid chromatography-tandem mass spectrometry system (Waters Corporation). Non-normally distributed data are expressed as median interquartile range (IQR) [M (P25, P75)]. Age- and sex-related differences were assessed using Mann-Whitney U or Kruskal-Wallis tests.

Analysis revealed that age significantly influences serum levels of B6-PL and B6-PA in children, while gender showed no significant effect. The pediatric cohort demonstrated a male predominance (58.98%, 860/1458) with a notable prepubertal skew (93.28%, 1360/1458 aged < 12 years). Further analysis facilitated the establishment of RIs for B6-PL and B6-PA across different age groups. The RIs for B6-PL were 1.62–17.70 ng/mL for children aged 1–5 years, 1.39–15.15 ng/mL for children aged 6–11 years, and 1.06–14.30 ng/mL for children aged 12–16 years. The RIs for B6-PA were 1.20–5.46 ng/mL for children aged 1–5 years, 1.10–4.41 ng/mL for children aged 6–11 years, and 0.95–4.99 ng/mL for children aged 12–16 years.

This study establishes the first age-stratified RIs for serum vitamin B6 metabolites (B6-PL and B6-PA) among children aged 1–16 years in Henan, China.

## Linked entities

- **Chemicals:** vitamin B6 (PubChem CID 1054), pyridoxal (PubChem CID 1050), pyridoxic acid (PubChem CID 6723)

## Full-text entities

- **Genes:** PLP1 (proteolipid protein 1) [NCBI Gene 5354] {aka GPM6C, HLD1, MMPL, PLP, PLP/DM20, PMD}
- **Diseases:** inflammatory (MESH:D007249), congenital anomalies (MESH:D000013), neurological disorders (MESH:D009461), febrile seizures (MESH:D003294), dermatological rashes (MESH:D005076), B6 (MESH:D026681), hematologic disorders (MESH:D006402), encephalitis (MESH:D004660), HHC (MESH:D020138), malignant tumors (MESH:D009369), status epilepticus (MESH:D013226), metabolic disorder (MESH:D008659), PLP deficiency (MESH:C566449), neurological sequelae (MESH:D009422), toxicity (MESH:D064420), epilepsy (MESH:D004827), hemolysis (MESH:D006461), diarrhea (MESH:D003967), infections (MESH:D007239), anemia (MESH:D000740), vomiting (MESH:D014839), gastrointestinal disturbances (MESH:D005767)
- **Chemicals:** arachidonic acid (MESH:D016718), B6 (-), glucose-1-phosphate (MESH:C031590), glycogen (MESH:D006003), amino acid (MESH:D000596), pyridine (MESH:C023666), PM (MESH:D011733), GABA (MESH:D005680), PMP (MESH:C091421), PL (MESH:D011730), PN (MESH:D011736), serotonin (MESH:D012701), PA (MESH:D011735), carbohydrates (MESH:D002241), Vitamin B6 (MESH:D025101), nitrogen (MESH:D009584), pyridoxal 5'-phosphate (MESH:D011732), lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12343249/full.md

---
Source: https://tomesphere.com/paper/PMC12343249